UK CLL Forum. Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients. haematol [Internet]. 2016Nov.30 [cited 2024Apr.18];101(12):1563-72. Available from: https://haematologica.org/article/view/7913